FDA Authorizes Emergency Use of Monkeypox Vaccine
The World Health Organization declared the monkeypox (MPV) outbreak a global health emergency last month. Then, President Biden’s administration declared the disease a public health emergency in the U.S.
on Thursday. Now, the Food and Drug Administration has authorized emergency use of the Jynneos vaccine against the disease, increasing a strained supply by five-fold."In recent weeks the monkeypox virus has continued to spread at a rate that has made it clear our current vaccine supply will not meet the current demand," said FDA Commissioner Robert M.
Califf, M.D. in a statement. "The FDA quickly explored other scientifically appropriate options to facilitate access to the vaccine for all impacted individuals.
By increasing the number of available doses, more individuals who want to be vaccinated against monkeypox will now have the opportunity to do so."The emergency use authorization will open up vaccine supplies to those deemed at high-risk for MPV, typically sexually-active men who have sex with men, and include both adults and high-risk adolescents.
